1. Introduction
===============

Cystatin C (CysC) is an extracellular inhibitor of cysteine proteases and is produced in all nucleated cells. CysC is freely filtered at the level of the renal glomeruli, and almost all of it is reabsorbed and metabolized in the proximal tubule.^\[[@R1],[@R2]\]^ CysC can be used as a measure of kidney function. In recent years, multiple studies have shown that CysC may be used as a more accurate indicator of glomerular filtration rate (GFR) than creatinine.^\[[@R3]--[@R7]\]^ CysC has also served as a predictive marker of cardiovascular disease.^\[[@R8],[@R9]\]^

Metabolic syndrome (MetS) is highly prevalent worldwide^\[[@R10]--[@R12]\]^ and is associated with an increased risk for cardiovascular disease and diabetes.^\[[@R13]--[@R15]\]^ Many studies on the treatment of MetS have recently been conducted, including studies examining complementary and alternative medicine (CAM) treatments and the use of berry fruits.^\[[@R16],[@R17]\]^ Some researchers have found that low testosterone concentration and high serum ferritin level were risk factors for MetS.^\[[@R18],[@R19]\]^ Others have demonstrated that CysC is associated with MetS^\[[@R20]--[@R23]\]^ and have reported a positive relationship between CysC, body mass index (BMI), and waist circumference (WC).^\[[@R20],[@R23]\]^ To the best of our knowledge, research on the association between MetS and CysC is limited. In the present study, we assessed the association of BMI, WC, and MetS with serum CysC in a large Chinese population.

2. Methods
==========

2.1. Study designs and population
---------------------------------

A total of 6306 subjects visited our health care center for their regular checkup between January and December 2013. The medical history, including medications, of each subject was obtained. Subjects with thyroid dysfunction, pregnancy, malignant disease, cirrhosis, infectious disease, active liver disease, chronic kidney disease, missing a valid measurement for necessary indices, or less than 18 years old were excluded (n = 440). Of the total sample (N = 5866), none had a history of corticosteroid or cyclosporine use, hyperhomocysteinemia, or rheumatic diseases.

2.2. Clinical indices and anthropometric measurements
-----------------------------------------------------

Venous blood samples were drawn after a 10-hour fast for serum index measurements. Triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), fasting plasma glucose (FPG), high-sensitivity C-reactive protein (hs-CRP), and serum creatinine (Scr) concentrations were measured using glycerol phosphate oxidase and peroxidase (GPO-POD), surfactant elution, selected inhibition, hexokinase, turbidimetric immunoassay, and sarcosine oxidase methods, respectively, using a Beckman Coulter AU 5400 machine. CysC concentrations were measured using the turbidimetric immunoassay method, specifically with a Beckman Coulter AU 5400 machine, at a reference range of less than 1.03 mg/L. Both the intra- and interassay coefficients of CysC were less than 10%. CysC levels were between 0.33 and 1.81 mg/L. Estimated glomerular filtration rate (Chronic Kidney Disease Epidemiology Collaboration) (eGFR~CKD-EPI~) equation^\[[@R24]\]^ was used. Blood pressure (BP) was measured after at least 5 minutes of rest. WC was measured on standing subjects with a measuring tape midway between the lowest rib and the iliac crest. Body weight was measured in kilograms (with light clothing), and height was measured in meters (without shoes). BMI was calculated by using the formula: Weight (kg)/\[Height (m)\]^2^.

MetS was diagnosed according to the American Heart Association/National Heart, Lung, and Blood Institute 2005 (NCEP-R),^\[[@R25]\]^ which requires at least 3 of the following criteria to be met: WC ≥90 cm in males and ≥80 cm in females; TG ≥1.7 mmol/L (150 mg/dL) or a specific treatment for TG; HDL-C \< 1.03 mmol/L (40 mg/dL) in males and \<1.29 mmol/L (50 mg/dL) in females or a specific treatment for reduced HDL-C; systolic blood pressure (SBP) ≥130 mm Hg, diastolic blood pressure (DBP) ≥85 mm Hg, or antihypertensive treatment; and FPG ≥5.6 mmol/L (100 mg/dL) or drug treatment for elevated glucose.

2.3. Ethical issues
-------------------

The ethical committee of the Second Affiliated Hospital, School of Medicine, Zhejiang University approved the study. All subjects provided informed consent.

2.4. Statistical analyses
-------------------------

SPSS software (version 13.0; SPSS Inc., Chicago, IL) was used for statistical analysis. Normal distribution data were expressed as the mean ± standard deviation. Skewed distribution data were expressed as the median with 25th and 75th percentiles (P~25~--P~75~). The Mann--Whitney *U* test was used to compare relevant data between non-MetS and MetS groups. The non-MetS group was defined as those subjects without MetS (2 or less MetS criteria). The Mann--Whitney *U* test was used to compare the data between the 1st and 4th quartiles of CysC. Logistic regression was performed to identify independent factors of MetS, and estimate odds ratios (ORs) and 95% confidence intervals (95% CIs) for the factors. The following were considered covariates in the logistic regression analysis: age, sex, hs-CRP, Scr, eGFR~CKD-EPI~, and CysC. SAS software (Version 9.2; SAS Institute Inc., Cay, NC) was used to perform a Spearman partial correlation analysis, adjusting for age and sex, to determine the association of BMI, WC, hs-CRP, Scr, and eGFR~CKD-EPI~ with CysC. *P* \< 0.05 was considered statistically significant.

3. Results
==========

3.1. Clinical characteristics
-----------------------------

The clinical data on this cohort are shown in Table [1](#T1){ref-type="table"}. A total of 5866 subjects were included in the study (females: 2081, males: 3785; age range: 18--84 years). Compared to the non-MetS group, the MetS group exhibited significantly higher levels of TG, LDL-C, FPG, hs-CRP, BMI, WC, SBP, DBP, Scr, and CysC, and lower levels of HDL-C and eGFR~CKD-EPI~.

###### 

Relevant data according to the presence or the absence (non-MetS) of MetS.
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3.2. CysC and other indices
---------------------------

The data were divided into 4 groups according to the quartiles of serum CysC concentration (Table [2](#T2){ref-type="table"}). Comparisons between the indices in the 1st and 4th quartiles showed significantly higher values for TG, LDL-C, FPG, hs-CRP, BMI, WC, SBP, DBP, and Scr, whereas both HDL-C and eGFR~CKD-EPI~ were significantly lower in the 4th quartile.

###### 

Comparison of data among the different quartiles of CysC.
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3.3. Logistic regression analysis
---------------------------------

Logistic regression analysis revealed that sex, age, hs-CRP, and CysC were independently associated with the presence of MetS (OR = 3.732, 1.028, 1.051, and 3.334; 95% CI: 2.396--5.812, 1.004--1.053, 1.027--1.075, and 2.259--4.919; *P* \< 0.001, 0.021, \<0.001, and \<0.001, respectively). No significant association was observed for presence of MetS and either Scr (*P* = 0.089) or eGFR~CKD-EPI~ (*P* = 0.253) (Table [3](#T3){ref-type="table"}).

###### 

Association of CysC, hsCRP and the presence of MetS in logistic regression models.
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3.4. Partial correlation analysis
---------------------------------

Spearman partial correlation coefficients of BMI, WC, hs-CRP, Scr, and eGFR~CKD-EPI~ with CysC are summarized in Table [4](#T4){ref-type="table"}. After adjustment for age and sex, the results indicated that BMI, WC, hs-CRP, and Scr were positively correlated with CysC, whereas eGFR~CKD-EPI~ was negatively correlated with CysC (*r* = 0.029, 0.061, 0.189, 0.227, and −0.210; *P* = 0.0260, \<0.0001, \<0.0001, \<0.0001, and \<0.0001, respectively).

###### 

Further partial correlation analysis between BMI, WC, hsCRP, Scr, and eGFR with CysC.
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4. Discussion
=============

MetS is characterized by high fasting blood glucose, TG, BP levels, elevated WC, and low HDL-C levels. The worldwide prevalence of MetS has recently been acknowledged as an important public health challenge.^\[[@R26]\]^ MetS was present in 26.1% of the current study subjects, identical to that found in the literature.^\[[@R10]--[@R12],[@R27]--[@R29]\]^ Furthermore, CysC concentrations were significantly higher in the MetS group than in the non-MetS group. Similar to our findings, Liu et al^\[[@R30]\]^ demonstrated higher serum CysC levels were positively and independently associated with the presence of MetS in a sample of Chinese premenopausal and postmenopausal women. Based on group-stratified CysC values, MetS significantly differed in the lowest CysC quartile compared to the highest quartile. Last, our data reflected a correlation between CysC and MetS.

The association between inflammation and MetS has been well documented.^\[[@R31],[@R32]\]^ A previous report suggested that chronic subclinical inflammation may be partly influenced by MetS.^\[[@R33]\]^ Some studies have suggested a significant association between CysC and CRP,^\[[@R34]--[@R36]\]^ and CysC may be considered as a potential inflammatory biomarker.^\[[@R21]\]^ Our data showed that CysC and hs-CRP were independent covariates of MetS. Partial correlation analysis indicated a positive correlation between CysC and hs-CRP, after adjusting for age and sex. Therefore, our data suggest an association between CysC and inflammation.

Logistic regression analysis showed that the CysC was more closely associated with the presence of MetS, as compared Scr or eGFR~CKD-EPI~. Previous studies demonstrated that CysC was considered as a "preclinical" state of renal disease, which was not detected with Scr or eGFR.^\[[@R37]\]^ Thus, CysC is considered to be an accurate glomerular marker for early renal insufficiency.^\[[@R38]\]^

After adjusting for age and sex, the results indicated that, besides hs-CRP, BMI and WC were also positively correlated with CysC. Although both *r*-values were low, CysC was more strongly correlated with WC than with BMI. Previous studies have shown associations between BMI, WC, and CysC.^\[[@R20],[@R23]\]^ CysC is an endogenous inhibitor of cathepsin proteases. A recent report has shown that CysC affects adipose tissue and vascular homeostasis through the inhibition of cathepsins.^\[[@R39]\]^ This particular study indicated that WC is more closely related to CysC than BMI. Magnusson et al^\[[@R20]\]^ showed that abdominal obesity is the only component of MetS that is significantly associated with increased baseline levels of CysC. Another study illustrated a stronger correlation between CysC and WC compared to BMI.^\[[@R40]\]^ These data indicate that the close association between CysC and MetS may be mediated by visceral fat.

A limitation of our study is that it only included subjects who visited our center for a checkup. The analysis was also limited by the cross-sectional design.

In conclusion, we found the CysC was more closely associated with the presence of MetS, as compared Scr or eGFR~CKD-EPI.~. CysC was positively correlated with BMI, and more strongly, positively correlated with WC and inflammation.
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